Shares of RxSIGHT, INC. (RXST) plunged 8.30% in pre-market trading on Monday, following a significant price target cut by Wells Fargo analysts. The sharp decline comes as investors react to the lowered expectations for the company's stock performance.

Wells Fargo has reduced its target price for RxSIGHT from $22 to $17, representing a substantial 23% decrease. This adjustment in valuation has seemingly shaken investor confidence, triggering a sell-off in the company's shares.

The reasons behind Wells Fargo's decision to lower the price target have not been explicitly stated in the available information. However, such revisions typically reflect changes in a company's financial outlook, market conditions, or sector-specific challenges. Investors and analysts will likely be looking for more details to understand the full implications of this target price reduction on RxSIGHT's future prospects.